Literature DB >> 11133342

International quit and win 1996: standardized evaluation in selected campaign countries.

T Korhonen1, A McAlister, M Laaksonen, T Laatikainen, P Puska.   

Abstract

BACKGROUND: Quit and Win '96 recruited 70,000 smokers in 25 countries. The participants tried to abstain from smoking for at least 4 weeks. All participating countries followed the jointly agreed rules. Half of the countries implemented the campaign nationally and half, regionally.
METHODS: A 1-year follow-up study was conducted in the participating countries. The aim of this study was to provide a standardized evaluation based on data from eight European campaign sites. Three measures were used to evaluate the effectiveness of the campaigns. The first measure was the participation rate, which is the proportion of participants among the smoking population targeted in each site. The second measure was a cautious estimate for the continuous 1-year abstinence rate, which is the proportion of abstainers among the follow-up sample regarding all non-respondents as relapsed. Third was the measure of the population impact, which is the efficacy of the intervention multiplied by its reach, where the efficacy equals the abstinence rate and the reach equals the participation rate.
RESULTS: The participation rates varied from 0.1 to 2%, being highest in North Karelia, Finland, and Pitka;auranta, Russia. The abstinence rates varied from 12 to 35%, being highest in Hungary, Ukraine, and Russia, where the prevalence of smoking is also relatively high. The population impacts varied from 0.02 to 0.5%, being highest in Pitka;auranta, where both the reach and the efficacy of the Quit and Win were relatively high.
CONCLUSIONS: There was great variation in effectiveness, with population impact being affected more by participation rate than abstinence rate. Quit and Win contests are feasible interventions in diverse European populations. To improve the effectiveness, future campaigns should increase the reach of the intervention. Copyright 2000 American Health Foundation and Academic Press.

Entities:  

Mesh:

Year:  2000        PMID: 11133342     DOI: 10.1006/pmed.2000.0766

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  7 in total

1.  Smoking cessation counseling by Russian oncologists: opportunities for intervention in the Russian Federation.

Authors:  Robert A Schnoll; Paul F Engstrom; Somasundaram Subramanian; Lev Demidov; Dustin B Wielt
Journal:  Int J Behav Med       Date:  2006

2.  Interventions to increase smoking cessation at the population level: how much progress has been made in the last two decades?

Authors:  Shu-Hong Zhu; Madeleine Lee; Yue-Lin Zhuang; Anthony Gamst; Tanya Wolfson
Journal:  Tob Control       Date:  2012-03       Impact factor: 7.552

3.  A block randomized controlled trial of a brief smoking cessation counselling and advice through short message service on participants who joined the Quit to Win Contest in Hong Kong.

Authors:  Sophia S C Chan; David C N Wong; Yee Tak Derek Cheung; Doris Y P Leung; Lisa Lau; Vienna Lai; Tai-Hing Lam
Journal:  Health Educ Res       Date:  2015-06-25

4.  Competitions for smoking cessation.

Authors:  Thomas R Fanshawe; Jamie Hartmann-Boyce; Rafael Perera; Nicola Lindson
Journal:  Cochrane Database Syst Rev       Date:  2019-02-20

5.  The WERO group stop smoking competition: main outcomes of a pre- and post- study.

Authors:  Marewa Glover; Anette Kira; Dudley Gentles; Nathan Cowie; Chris Paton; Warren Moetara
Journal:  BMC Public Health       Date:  2014-06-13       Impact factor: 3.295

6.  Tobacco control in the Russian Federation--a policy analysis.

Authors:  Karsten Lunze; Luigi Migliorini
Journal:  BMC Public Health       Date:  2013-01-23       Impact factor: 3.295

7.  An innovative team-based stop smoking competition among Māori and Pacific Island smokers: rationale and method for the study and its evaluation.

Authors:  Marewa Glover; Amber Bosman; Annemarie Wagemakers; Anette Kira; Chris Paton; Nathan Cowie
Journal:  BMC Public Health       Date:  2013-12-23       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.